Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Perspective Therapeutics: Aktie stürzt nach Studiendaten zu Krebstherapie ab (Investing.com DE) +++ PERSPECTIVE THERAPEUTICS Aktie +3,01%

IRONWOOD Aktie

 >IRONWOOD Aktienkurs 
1.31 EUR    (Tradegate)
Ask: 1.34 EUR / 2226 Stück
Bid: 1.28 EUR / 2356 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
IRONWOOD Aktie über LYNX handeln
>IRONWOOD Performance
1 Woche: +0,8%
1 Monat: +2,3%
3 Monate: +94,1%
6 Monate: +98,5%
1 Jahr: -68,0%
laufendes Jahr: -69,1%
>IRONWOOD Aktie
Name:  IRONWOOD PHARMA.A DL-,001
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US46333X1081 / A0X789
Symbol/ Ticker:  I76 (Frankfurt) / IRWD (NASDAQ)
Kürzel:  FRA:I76, ETR:I76, I76:GR, NASDAQ:IRWD
Index:  -
Webseite:  http://www.ironwoodpharma..
Profil:  Ironwood Pharmaceuticals Inc. is a healthcare and ..
>Volltext..
Marktkapitalisierung:  199.32 Mio. EUR
Unternehmenswert:  629.84 Mio. EUR
Umsatz:  264.74 Mio. EUR
EBITDA:  89.16 Mio. EUR
Nettogewinn:  -5.97 Mio. EUR
Gewinn je Aktie:  -0.04 EUR
Schulden:  513.72 Mio. EUR
Liquide Mittel:  79.68 Mio. EUR
Operativer Cashflow:  25.73 Mio. EUR
Bargeldquote:  0.4
Umsatzwachstum:  -29.97%
Gewinnwachstum:  -168.62%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  IRONWOOD
Letzte Datenerhebung:  21.10.25
>IRONWOOD Kennzahlen
Aktien/ Unternehmen:
Aktien: 162.43 Mio. St.
Frei handelbar: 96.26%
Rückkaufquote: -0.13%
Mitarbeiter: 253
Umsatz/Mitarb.: 1.19 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: -40.1%
Bewertung:
KGV: -
KGV lG: 7.81
KUV: 1
KBV: -
PEG-Ratio: -
EV/EBITDA: 7.06
Rentabilität:
Bruttomarge: 99.37%
Gewinnmarge: -2.25%
Operative Marge: 33.05%
Managementeffizenz:
Gesamtkaprendite: -1.88%
Eigenkaprendite: -
>IRONWOOD Peer Group

Es sind 599 Aktien bekannt.
 
15.10.25 - 14:06
Long-Time Commonwealth Advisor Gigi Schneppat Joins Cetera (PR Newswire)
 
Seeking growth and the benefits of a larger team environment, Schneppat aligns with Ironwood Family Wealth Advisors, part of the Cetera Investors Community SAN DIEGO, Oct. 15, 2025 /PRNewswire/ -- Cetera welcomes financial advisor Gigi Schneppat, who joins after 15 years with Commonwealth......
15.10.25 - 13:45
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics (Zacks)
 
Small-cap biotech momentum surges as AKBA, IRWD, PYXS, CRDL, and PSTV gain on pipeline progress and sector recovery....
22.09.25 - 15:09
Teeing Up Futures: Spectrum Investment Advisors Cristo Rey Scholarship Golf Outing (PR Newswire)
 
MEQUON, Wis., Sept. 22, 2025 /PRNewswire/ -- On August 27th, Spectrum Investment Advisors proudly hosted the annual Cristo Rey Memorial Golf Outing at Ironwood Golf Course—a day filled with purpose, community, and celebration. This year, we raised $23,000, allowing us to award two......
09.09.25 - 15:03
High-Grade Gold Intersected on Globex′s Kewagama Gold Royalty Claims (GlobeNewswire EN)
 
ROUYN-NORANDA, Quebec, Sept. 09, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to provide an additional update as regards drilling by Radisson Mining Resources Inc. (RDS-TSXV, RMRDF-OTCQB) on Globex's Kewagama Gold Mine Royalty claims. Globex holds a two percent (2%) Net Smelter Royalty (NSR) on the eastern portion of what Radisson calls East O'Brien, including all the Kewagama Gold Mine royalty claims eastward to the adjoining 100% Globex owned Central Cadillac/Wood Gold Mines property including the Ironwood gold deposit.  ...
28.08.25 - 10:06
Google′s new TPU Ironwood delivers leap in computing power, integrating 9,216 chips (Digitimes)
 
The AI infrastructure arms race is escalating at an unprecedented pace. At Hot Chips 2025, Google unveiled more details about its next-generation TPU platform, Ironwood, and how it scales at the rack level. Released in April 2025, Ironwood's remarkable performance leap once again raises the bar in this fierce AI competition....
14.08.25 - 00:01
Insiderhandel: Principal Accounting Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 2391 USD (Insiderkauf)
 
Silver, Ronald - Vorstand - Tag der Transaktion: 2025-08-11...
14.08.25 - 00:01
Insiderhandel: Chief Commercial Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 1105 USD (Insiderkauf)
 
Gaskins, Tammi L. - Vorstand - Tag der Transaktion: 2025-08-11...
14.08.25 - 00:01
Insiderhandel: Chief Legal Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 6513 USD (Insiderkauf)
 
John, Minardo - Vorstand - Tag der Transaktion: 2025-08-11...
14.08.25 - 00:01
Insiderhandel: Chief Financial Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 1063 USD (Insiderkauf)
 
Martini, Gregory S. - Vorstand - Tag der Transaktion: 2025-08-11...
08.08.25 - 18:15
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates (Zacks)
 
Ironwood shares jump 9.3% as second-quarter earnings and revenues top estimates. The company maintains its 2025 outlook....
07.08.25 - 16:36
Ironwood (IRWD) Q2 EPS Jumps 600% (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.25 - 16:00
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates (Zacks)
 
Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?...
07.08.25 - 13:09
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance (Business Wire)
 
– LINZESS® (Iinaclotide) U.S. net sales of $248 million in Q2 2025; EUTRx demand growth of 10% year-over-year – – Plans to align with FDA on confirmatory Phase 3 trial design in Q4 2025 – – Progressing previously announced strategic alternatives review to maximize shareholder value –BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today reported its second quarter 2025 results and recent business performance. “In the second quarter, LINZESS delivered $248 million in U.S. net sales with robust EUTRx demand growth of 10% year-over-year. Additionally, LINZESS net price was in-line with our expectations for the quarter, further reinforcing our belief that we are on track to achieve our latest full year 2025 financial guidance. For apraglutide, we have been finalizing a confirmatory Phase 3 trial design and plan to align with the FD...
29.07.25 - 13:09
Kyle Bass and Terry Anderson′s Conservation Equity Management and Ironwood Resource Advisors Announce Approval of Largest Tidal Wetland Mitigation Project in Texas History (PR Newswire)
 
BRAZORIA COUNTY, Texas, July 29, 2025 /PRNewswire/ -- Conservation Equity Management (CEM) https://www.cem-tx.com/ and Ironwood Resource Advisors, LLC are proud to announce the federal approval of the Frentress-Johnson West Bay Mitigation Bank (FJWB)—the largest tidal wetland mitigation......
22.07.25 - 15:57
Firm led by Father and Two Sons Joins Cetera Seeking Community (PR Newswire)
 
Ironwood Family Wealth Advisors joins Cetera Investors from Osaic SAN DIEGO, July 22, 2025 /PRNewswire/ -- Cetera welcomes Ironwood Family Wealth Advisors (Ironwood), led by founder Torsten "Tor" Saile, and his sons Tyler Saile and Tanner Saile, who left Osaic to affiliate with Cetera.......
10.06.25 - 15:54
Ironwood Drilling Upgrades Gold Resource to Indicated from Inferred (GlobeNewswire EN)
 
ROUYN-NORANDA, Quebec, June 10, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang & Schwarz, LS Exchange, TTMzero, Düsseldorf and Quotrix Düsseldorf Stock Exchanges and GLBXF – OTCQX International in the US) is pleased to inform shareholders as regards to the completion of the NI 43-101 Technical Report on Globex's 100% owned Ironwood Gold Deposit received on May 30th. The report titled “NI 43-101 Technical Report, Ironwood Gold Deposit, Cadillac, Quebec, Canada, by SLR Consulting (Canada) Ltd., effective April 15, 2025, was written by Qualified Person Reno Pressacco, M.Sc. (A), P.Geo., FGC. and will be filed on Sedar within 45 days....
02.06.25 - 22:09
The Ensign Group Acquires Two Skilled Nursing Facilities in Idaho (GlobeNewswire EN)
 
SAN JUAN CAPISTRANO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of Ironwood Rehabilitation and Care Center, an 80-bed skilled nursing facility located in Coeur d'Alene, Idaho and Lakeside Rehabilitation and Care Center, a 100-bed skilled nursing facility also located in Coeur d'Alene, Idaho. These acquisitions were effective June 1, 2025 and are subject to a long-term, triple net master lease with a third-party landlord....
28.05.25 - 14:09
Conservation Equity Management and Ironwood Resource Advisors Announce Historic Approval of First Eastern Black Rail Conservation Bank in U.S. (PR Newswire)
 
GALVESTON, Texas, May 28, 2025 /PRNewswire/ -- Conservation Equity Management (CEM) https://www.cem-tx.com and Ironwood Resource Advisors, LLC are proud to announce the establishment of the first-ever Eastern Black Rail Conservation Bank (EBRCB), approved by the U.S. Fish and Wildlife......
21.05.25 - 01:01
Insiderhandel: Chief Commercial Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 1487 USD (Insiderkauf)
 
Gaskins, Tammi L. - Vorstand - Tag der Transaktion: 2025-05-16...
21.05.25 - 01:01
Insiderhandel: Chief Executive Officer verkauft Aktien von Ironwood Pharmaceuticals im Wert von 7745 USD (Insiderkauf)
 
Mccourt, Thomas A. - Vorstand - Tag der Transaktion: 2025-05-16...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ein gelegtes Ei kann zum Findling werden. - Dr. Fritz P. Rinnhofer
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!